Healthcare provider profile · identity verified

Darcy M Conner, D.O.

Family Practice · VIENNA, WV · NPI 1720004559

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	476	120
Alprazolam	Alprazolam	282	54
Atorvastatin Calcium	Atorvastatin Calcium	241	78
Omeprazole	Omeprazole	234	66
Lisinopril	Lisinopril	229	65
Rosuvastatin Calcium	Rosuvastatin Calcium	226	67
Amlodipine Besylate	Amlodipine Besylate	206	64
Meloxicam	Meloxicam	198	60
Sertraline Hcl	Sertraline Hcl	173	39
Metoprolol Succinate	Metoprolol Succinate	167	50
Hydrochlorothiazide	Hydrochlorothiazide	164	50
Losartan Potassium	Losartan Potassium	163	52
Pantoprazole Sodium	Pantoprazole Sodium	146	48
Gabapentin	Gabapentin	144	49
Metoprolol Tartrate	Metoprolol Tartrate	128	33
Metformin Hcl	Metformin Hcl	126	43
Mounjaro	Tirzepatide	122	19
Metformin Hcl Er	Metformin Hcl	117	42
Pregabalin	Pregabalin	106	17
Simvastatin	Simvastatin	105	29
Trazodone Hcl	Trazodone Hcl	105	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	104	17
Zolpidem Tartrate	Zolpidem Tartrate	97	19
Eliquis	Apixaban	89	22
Alendronate Sodium	Alendronate Sodium	88	27
Celecoxib	Celecoxib	83	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	22
Pioglitazone Hcl	Pioglitazone Hcl	78	21
Tramadol Hcl	Tramadol Hcl	74	20
Allopurinol	Allopurinol	71	14
Fluoxetine Hcl	Fluoxetine Hcl	69	21
Potassium Chloride	Potassium Chloride	69	18
Duloxetine Hcl	Duloxetine Hcl	67	22
Fluticasone Propionate	Fluticasone Propionate	65	24
Synthroid	Levothyroxine Sodium	63	17
Escitalopram Oxalate	Escitalopram Oxalate	61	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	24
Montelukast Sodium	Montelukast Sodium	57	26
Albuterol Sulfate Hfa	Albuterol Sulfate	51	18
Estradiol	Estradiol	51	17
Jardiance	Empagliflozin	50	suppressed
Furosemide	Furosemide	49	24
Lorazepam	Lorazepam	46	suppressed
Pravastatin Sodium	Pravastatin Sodium	46	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	15
Atenolol	Atenolol	44	14
Trulicity	Dulaglutide	44	11
Diclofenac Sodium	Diclofenac Sodium	43	12
Esomeprazole Magnesium	Esomeprazole Magnesium	43	11
Ibuprofen	Ibuprofen	43	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Famotidine	Famotidine	41	13
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	13
Clopidogrel	Clopidogrel Bisulfate	35	11
Fenofibrate	Fenofibrate Nanocrystallized	35	12
Hydralazine Hcl	Hydralazine Hcl	35	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	11
Meclizine Hcl	Meclizine Hcl	34	12
Ondansetron Hcl	Ondansetron Hcl	34	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	11
Carvedilol	Carvedilol	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Methocarbamol	Methocarbamol	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Belsomra	Suvorexant	25	suppressed
Ozempic	Semaglutide	25	11
Torsemide	Torsemide	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Ezetimibe	Ezetimibe	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Temazepam	Temazepam	22	suppressed
Topiramate	Topiramate	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Valsartan	Valsartan	21	suppressed
Wegovy	Semaglutide	21	suppressed
Prednisone	Prednisone	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Nystatin	Nystatin	19	14
Tradjenta	Linagliptin	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Diazepam	Diazepam	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	17
Methylprednisolone	Methylprednisolone	17	17
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Cefdinir	Cefdinir	16	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Levofloxacin	Levofloxacin	14	14
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	11
Fluconazole	Fluconazole	12	11
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Promethazine Hcl	Promethazine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error